4.5 Article

Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels

Journal

JOURNAL OF BIOMEDICAL OPTICS
Volume 18, Issue 8, Pages -

Publisher

SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
DOI: 10.1117/1.JBO.18.8.087002

Keywords

normal; moderately metastatic and advanced metastatic cell lines; native fluorescence spectra; optical biopsy; metastasis-relevant key fluorophores; tryptophan; NADH

Funding

  1. U.S. Army Medical Research and Material Command [W81XWH-11-1-0335, W81XWH-08-1-0717]
  2. National Institutes of Health [NIBIB R01 EB008111, NCI R01 CA171651]

Ask authors/readers for more resources

The spectral changes of native fluorophores among normal fibroblasts and cancer cell lines of different metastatic ability are investigated by fluorescence spectroscopy. The normal (fibroblast), moderately metastatic (DU-145), and advanced metastatic (PC-3) cell lines were each selectively excited at 300 nm, and their fluorescence emission spectra are analyzed using principal component analysis to explore the differences of the relative contents of tryptophan and reduced nicotinamide adenine dinucleotide in these cell lines. The results show that the tryptophan emission featured predominantly in the fluorescence spectra of the advanced metastatic cancer cells in comparison with the moderately metastatic cancer and normal cells. (C) 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Pattern recognition analysis of dynamic susceptibility contrast (DSC)-MRI curves automatically segments tissue areas with intact blood-brain barrier in a rat stroke model: A feasibility and comparison study

Seokha Jin, SoHyun Han, Radka Stoyanova, Ellen Ackerstaff, HyungJoon Cho

JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)

Article Chemistry, Multidisciplinary

Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma

Rui Tang, Alexander Zheleznyak, Matthew Mixdorf, Anchal Ghai, Julie Prior, Kvar C. L. Black, Monica Shokeen, Nathan Reed, Pratim Biswas, Samuel Achilefu

ACS NANO (2020)

Review Chemistry, Multidisciplinary

Head-Mounted Devices for Noninvasive Cancer Imaging and Intraoperative Image-Guided Surgery

Suman B. Mondal, Shaw-Wei D. Tsen, Samuel Achilefu

ADVANCED FUNCTIONAL MATERIALS (2020)

Article Biochemical Research Methods

Distinguishing metastatic triple-negative breast cancer from nonmetastatic breast cancer using second harmonic generation imaging and resonance Raman spectroscopy

Ethan Bendau, Jason Smith, Lin Zhang, Ellen Ackerstaff, Natalia Kruchevsky, Binlin Wu, Jason A. Koutcher, Robert Alfano, Lingyan Shi

JOURNAL OF BIOPHOTONICS (2020)

Article Engineering, Biomedical

Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2

Duanwen Shen, Baogang Xu, Kexian Liang, Rui Tang, Gail P. Sudlow, Christopher Egbulefu, Kevin Guo, Avik Som, Rebecca Gilson, Dolonchampa Maji, Suman Mondal, LeMoyne Habimana-Griffin, Walter J. Akers, Shunqiang Li, Yang Liu, Sharon Bloch, Sid Kurkure, Zohar Nussinov, Alexander Seidel, Shaw-Wei D. Tsen, Samuel Achilefu

NATURE BIOMEDICAL ENGINEERING (2020)

Article Engineering, Biomedical

Ultrabright fluorescent nanoscale labels for the femtomolar detection of analytes with standard bioassays

Jingyi Luan, Anushree Seth, Rohit Gupta, Zheyu Wang, Priya Rathi, Sisi Cao, Hamed Gholami Derami, Rui Tang, Baogang Xu, Samuel Achilefu, Jeremiah J. Morrissey, Srikanth Singamaneni

NATURE BIOMEDICAL ENGINEERING (2020)

Article Oncology

Lactate Dehydrogenase A Depletion Alters MyC-CaP Tumor Metabolism, Microenvironment, and CAR T Cell Therapy

Mayuresh M. Mane, Ivan J. Cohen, Ellen Ackerstaff, Khalid Shalaby, Jenny N. Ijoma, Myat Ko, Masatomo Maeda, Avi S. Albeg, Kiranmayi Vemuri, Jaya Satagopan, Anna Moroz, Juan Zurita, Larissa Shenker, Masahiro Shindo, Tanner Nickles, Ekaterina Nikolov, Maxim A. Moroz, Jason A. Koutcher, Inna Serganova, Vladimir Ponomarev, Ronald G. Blasberg

MOLECULAR THERAPY-ONCOLYTICS (2020)

Article Oncology

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

Kinan Alhallak, Jennifer Sun, Katherine Wasden, Nicole Guenthner, Julie O'Neal, Barbara Muz, Justin King, Daniel Kohnen, Ravi Vij, Samuel Achilefu, John F. DiPersio, Abdel Kareem Azab

Summary: This study developed nanoparticle-based bispecific T-cell engagers (nanoBiTEs) and nanoparticles targeting multiple cancer antigens (nanoMuTEs), overcoming the major limitations of current T-cell-based immunotherapy. These novel nanoparticles have a long half-life, enabling once-a-week administration while maintaining efficacy, with nanoMuTEs targeting multiple cancer antigens showing greater efficacy in myeloma cells.

LEUKEMIA (2021)

Article Multidisciplinary Sciences

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours

Roberta Zappasodi, Inna Serganova, Ivan J. Cohen, Masatomo Maeda, Masahiro Shindo, Yasin Senbabaoglu, McLane J. Watson, Avigdor Leftin, Rachana Maniyar, Svena Verma, Matthew Lubin, Myat Ko, Mayuresh M. Mane, Hong Zhong, Cailian Liu, Arnab Ghosh, Mohsen Abu-Akeel, Ellen Ackerstaff, Jason A. Koutcher, Ping-Chih Ho, Greg M. Delgoffe, Ronald Blasberg, Jedd D. Wolchok, Taha Merghoub

Summary: By blocking CTLA-4, metabolic fitness and immune cell infiltration in tumours, especially those with low glycolytic activity, can be enhanced. This improves therapeutic outcomes, particularly in tumours with defective glycolysis, by destabilizing T-reg cells and promoting the activity of tumour-specific CD8(+) T cells.

NATURE (2021)

Article Chemistry, Physical

Side-chain modification of collagen-targeting peptide prevents dye aggregation for improved molecular imaging of arthritic joints

Megan S. Michie, Baogang Xu, Gail Sudlow, Luke E. Springer, Christine T. N. Pham, Samuel Achilefu

Summary: In this study, NIR dye-peptide conjugates were synthesized and it was found that a peptide-driven strategy can alter the aggregation states of molecular probes in aqueous solutions, leading to effective imaging of inflammatory arthritis joints. The results suggest that peptide plays a dominant role in controlling the photophysical properties of these bioconjugates.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2022)

Article Hematology

S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice

Sena Kim, Sora Lim, Boram Kim, Julie Ritchey, Kiran Vij, Julie Prior, Lynne Marsala, Alyssa Stoner, Feng Gao, Samuel Achilefu, Matthew L. Cooper, John F. DiPersio, Jaebok Choi

Summary: By blocking the IFNGR signaling pathway, S100A9 is upregulated in T cells and acts as a novel suppressor of graft-versus-host disease (GVHD) while preserving graft-versus-leukemia (GVL) effects. In both mouse models of allo-HSCT and xenogeneic human peripheral blood mononuclear cell transplantation, overexpression of S100A9 or administration of anti-IFNGR antibody improved GVHD without compromising GVL and reduced T-cell trafficking to GVHD target organs.

BLOOD (2023)

Article Rheumatology

Non-invasive monitoring of arthritis treatment response via targeting of tyrosine-phosphorylated annexin A2 in chondrocytes

Shaw-Wei D. Tsen, Luke E. Springer, Krishna Sharmah Gautam, Rui Tang, Kexian Liang, Gail Sudlow, Amir Kucharski, Christine T. N. Pham, Samuel Achilefu

Summary: LS301 selectively accumulates in regions of joint pathology in mouse models of RA, with a positive correlation with disease severity. Whole-body near-infrared imaging with LS301 allows tracking of spontaneous disease remission and therapeutic response after dexamethasone treatment. Histological analysis shows preferential accumulation of LS301 within chondrocytes and articular cartilage in arthritic mice, with colocalization observed between LS301 and pANXA2 in joint tissue.

ARTHRITIS RESEARCH & THERAPY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

Anchal Ghai, Alexander Zheleznyak, Matt Mixdorf, Julie O'Neal, Julie Ritchey, Michael Rettig, John DiPersio, Monica Shokeen, Samuel Achilefu

Summary: This study demonstrates the feasibility of [Zr-89]DFO-elotuzumab as a companion diagnostic for CS1-targeted therapies.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Meeting Abstract Oncology

CTLA-4 BLOCKADE PROMOTES TREG GLUCOSE METABOLISM AND REDUCES TREG FUNCTIONAL STABILITY IN GLYCOLYSIS-DEFECTIVE TUMORS

Roberta Zappasodi, Inna Serganova, Ivan Cohen, Masatomo Maeda, Yasin Senbabaoglu, Masahiro Shindo, Rachana Maniyar, Mayuresh Mane, Avigdor Leftin, McLane Watson, Svena Verma, Matthew Lubin, Myat Kyaw Ko, Arnab Ghosh, Mohsen Abu-Akeel, Ellen Ackerstaff, Jason Koutcher, Ping-Chih Ho, Greg Delgoffe, Ronald Blasberg, Jedd Wolchok, Taha Merghoub

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Meeting Abstract Oncology

CTLA-4 blockade drives loss of regulatory T cell functional stability in glycolysis defective tumors

Roberta Zappasodi, Inna Serganova, Ivan Cohen, Masatomo Maeda, Masahiro Shindo, Yasin Senbabaoglu, Avigdor Leftin, Rachana Maniyar, Svena Verma, Matthew Lubin, Myat Kyaw Ko, Mayuresh M. Mane, Arnab Ghosh, Ellen Ackerstaff, Jason A. Koutcher, Ping-Chih Ho, Greg M. Delgoffe, Ronald Blasberg, Jedd D. Wolchok, Taha Merghoub

CANCER RESEARCH (2020)

No Data Available